SCHEMBL25075692

SCHEMBL25075692

CC(C)(C)[C@H](NCC(F)(F)F)C(=O)N[C@@H](CC1CC1)C(=O)N[C@H](C#N)C[C@@H]1CCCNC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25075786 1.00 — —
SCHEMBL25075887 0.95 CTSV (0.49) —
SCHEMBL25075925 0.85 CTSV (0.38) —
SCHEMBL25075797 0.85 CTSV (0.38) —
SCHEMBL25075921 0.85 CTSV (0.39) —
SCHEMBL25075787 0.85 CTSV (0.40) —
SCHEMBL25075788 0.85 CTSV (0.39) —
SCHEMBL25075922 0.85 CTSV (0.40) —
SCHEMBL25075877 0.84 CTSV (0.40) —
SCHEMBL24740272 0.84 CTSV (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023023631-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. (US) 2023-02-23 — — WO disclosed
Send feedback